Introduction
Experimental exposure of sheep and rodents to infecting agents has revealed the influence of host genes on features such as disease susceptibility or disease incubation period of spongiform encephalopathies (SE) (for review, see Dickinson & Outram, 1988) . The PrP gene (Oesch et al., 1985) is the host gene most closely associated with disease and polymorphic variants of its product, the PrP protein, have been linked in rodents to differences in incubation period, and in man to incidence of disease (for reviews, see Westaway et al., 1989 and Brown, 1992) . Recently, we have shown that high and low disease susceptibility after challenge of Cheviot sheep with the SSBP/1 source of scrapie (Dickinson & Outram, 1988) was associated with structural differences in the PrP proteins encoded (Goldmann et al., 1991a) . PrP dimorphisms at codons 136, 154 and 171 have been described for these sheep resulting in four variant PrP alleles: Alala6Arg154Glnm, Ala136His~4Gln171, Ala136Arg,Arg m and Valla6Argt~4Gln .. Positive-line (high susceptibility) Cheviot sheep, which carry the PrP variant with Vale36 (both homozygotes and heterozygotes) are 100% susceptible to subcutaneous (s.c.) inoculation of SSBP/1 scrapie. Negative-line Cheviots, which are homozygous for Ala136, survive s.c. challenge, although a small proportion have been shown to succumb to disease after intracerebral (i.c.) inoculation (Dickinson et al., 1968) . A similar PrP genotype association with disease incidence has been described for experimental and natural scrapie in American Cheviot sheep (Maciulis et al., 1992) , in Swaledale sheep (Hunter et al., 1993) and Ile de France and Romanov sheep .
However, the situation is more complex than a simple association between one particular polymorphic form of the PrP gene, e.g. the Va1136 allele, and increased susceptibility to disease. Sheep with PrP genotypes known to be highly susceptible to SSBP/1 have a much lower disease incidence following injection with either isolates of bovine SE (BSE) or the scrapie source CH1641 (Foster & Dickinson, 1988) , and there is no apparent association between 'positive-line' and 'negative-line' Cheviot sheep with disease incidence caused by the latter two sources of agent. We therefore analysed the PrP genotypes of Cheviot sheep challenged with BSE, CH1641 or SSBP/1 scrapie by DNA sequencing and restriction fragment length polymorphism analysis of the PrP coding region. We have been able to identify the alleles important in determining susceptibility of sheep to BSE and the CH1641 isolate of sheep scrapie. As a consequence, disease incidence and the ranking of incubation period in challenged sheep can also be closely correlated to specific PrP genotypes for those isolates.
Inoculations. Animals were challenged by i.c. injection or by an oral route (Foster & Dickinson, 1988; Foster et al., 1993) and analysed biochemically for the disease-specific isoform of PrP (Hope et al., 1988) as described previously. Incubation period was taken to be the time between inoculation and euthanasia of clinically positive animals. Group data are analysed with reference to S.E.M. or S.D. (a). The BSE homogenate is a pool of four infected cattle brains (Fraser et al., 1992; Foster et al., 1993) . SSBP/1 is a brain pool of sheep-passaged scrapie. The details of the passage history of this isolate are described by Dickinson (1976) ; briefly, a brain pool of Cheviot and Cheviot x Border Leicester cross natural scrapie was passaged mostly through Cheviot sheep resulting in the 23rd and 24th passage, of which a pool was used in the described experimental cases. The isolate CH 1641 is derived from a positive-line NPU Cheviot (Foster & Dickinson, 1988) and passaged three times through single negative-line Cheviots before a pool of five infected brains was produced, and used for the described experiments. This pool has only been used for inoculation of negative-line Cheviots; positive-line sheep with the Vail3 n PrP allele are therefore not included in this study.
In vitro DNA amplification by PCR and DNA analysis. High M r DNA was made from blood, liver or brain tissue by using an Applied Biosystems Nucleic Acid Extractor (340A) which uses a modification of the method of Blin & Stafford (1976) . The PrP coding region was amplified by PCR (Saiki et al., 1985) , using 1 to 2 gg of genomic DNA in standard PCR buffer containing 150 gM of dNTPs, one unit of TaqI polymerase and 20 pmol of PrP-specific primer oligonucleotides (622) CACATAGGCAGTTGGATCCTGGTTCTC and (557) ATAATGAAAACAGGAAGGTTGCCCCTATCC (Goldmann et al., 1990) . PCR was carried out for 30 cycles consisting of denaturation at 94 °C for 1.5 rain, annealing at 62 °C for 2-5 min, and extension at 72 °C for 2 min. PCR-amplified DNA fragments were purified from agarose gels using a DEAE membrane as recommended by the manufacturer (NA45, Schleicher & Schuell). DNA fragments were digested with BspHI to determine the amino acid encoded in codons 136 and 154 (Hunter et al., 1993) . PCR fragments were also partially sequenced to determine the amino acids in codon 171 (and 154) using only ATP and GTP reactions with a PCR fragment-specific sequencing protocol. Usually, a fragment from one-quarter of the PCR reaction products (about 50 to 100 ng) is denatured for 3 min at 90 °C, mixed with 370 kBq [35S]dATP, oligonucleotide (30 pmol/reaction), 2 units Sequenase (USB) and incubated as follows: annealing for 30 rain at 37 °C, extension I for 5 min at 37 °C and extension II (ddNTPs) for 5 min at 50 °C.
Description ofPrP polymorphisms. We have used codon positions to describe the PrP dimorphisms in the sheep gene as previously described (Hunter et al., 1993) .
Results

Association of ovine PrP codon 136 and 171 dimorphisms with BSE
Seven out of 23 BSE-challenged sheep developed neuropathologically and biochemically confirmed SE, four died from other diseases and 12 sheep were free of clinical signs of scrapie for 5 years (> 1810 days) postinoculation (p.i.) and they are still alive at time of writing (Table 1) .
The result of the PrP genotype analysis of these sheep was as follows. Four out of 11 sheep challenged i.c. developed SE (Table 1 a ). There were two intercurrent deaths at 12 and 883 days p.i. (not genotyped). The remaining group included four sheep from the positive line (two affected sheep), with (Val/Ala)13 ~ PrP genotypes and five sheep from the negative line (two affected sheep), with (Ala/Ala)a36 PrP genotypes. All four affected sheep were homozygous Gln/Gln at codon 171, whereas all five survivors were heterozygous (Gln/Arg)m (Table 1 a) .
Three out of 12 sheep challenged orally with BSE succumbed to SE (Table l b) and there were two intercurrent deaths at 655 and 755 days p.i. in this group [only the second case was genotyped: (Ala/Ala)13~ (Gln/Arg)m]. The affected sheep were all homozygous (Gin/Gin)m, but represented all three possible PrP genotypes in codon 136: Val/Val, Val/Ala and Ala/Ala. Five survivors carried the Argm allele, with two heterozygous (Val/Ala)~3, and three homozygous (Ala/Ala)136 genotypes. There were also two homozygous (Ala/Ala)136 (Gin/Gin)iT1 survivors. Although the data for the peripheral route of infection appear to be less clear cut in the association of susceptibility and incubation period with PrP genotypes, the results as a whole show that only (Gin/Gin)iT1 sheep succumbed to the BSE isolate and emphasize a dominance of the Arg m allele in the delay or prevention of disease development.
There is, however, a modulating effect ofcodon 136 on the response of sheep to BSE. Following i.c. inoculation those affected sheep with the (Val/Ala)aa 6 genotype had 70% longer incubation periods than those with the (Ala/Ala)~36 genotype (Table 1 a) . Oral exposure to BSE appears to produce shorter incubation periods in homozygous genotypes compared to heterozygous (Val/Ala)~36 sheep (Table l b) . Thus the disease consequences of particular mutations of the PrP gene have to be considered within the context of the isolate of infecting agent and the presence of other mutations of the gene.
Association of ovine PrP codon 171 dimorphisms with CH1641 scrapie
The BSE results led to the question of whether the polymorphism of codon 171 is associated only with BSE susceptibility in sheep or whether it also operates similarly with strains of scrapie. To answer this, we analysed sheep inoculatd with scrapie source CH1641 (Table 2 ) and compared the data with our study of SSBP/1 scrapie (Table 3) . Twenty-three negative-line Cheviot sheep (low susceptibility to SSBP/1 scrapie) injected i.c. with CH1641 were genotyped; they were all homozygous (Ala/Ala)13~. Seven animals (30%) had clinically and neuropathologically confirmed scrapie with a mean incubation period of 358_ 19 days (S.E.M.). All seven were found to have a homozygous (Gin/Gin)iT1 PrP genotype (Table 2a ). The remaining 16 animals survived for 600 days or longer, with four sheep still alive (Table 2a) . Three sheep injected s.c. with CH1641 were also PrP genotyped. Only one of these had been affected by scrapie (with an incubation period three times longer than the mean for i.c. challenge) and this animal also had a homozygous (Gln/Gln)m genotype (Table 2b) .
Association of sheep PrP codon 136 and 171 dimorphisms with SSBP/1 scrapie
Two positive-line and three negative-line Cheviot sheep were challenged i.c. with SSBP/1. One of two affected animals had a heterozygous genotype, (Val/Ala)la 6 (Gln/Arg)m (Table 3 a ). This result is consistent with the previous association of Valla G with susceptibility to peripheral (s.c.) SSBP/1 challenge (Goldmann et al., 1991 a) and shows that the Valla 6 allele is dominant over the Arg m allele in SSBP/1 scrapie, in contrast to BSE and CH1641. Conversely, two SSBP/I i.c. challenged sheep of the (Ala/Ala)~a ~ (Gin/Gin) m genotype, which would be susceptible to BSE and CHt641, are still alive at the time of writing, 1350 days p.i. (Table 3 a) . There is a 36 % difference in the incubation period between the homozygous (Gln/Gln)171 sheep and the heterozygous (Gln/Arg)17~ sheep in the i.c. route of infection, suggesting a modulation associated with codon 171 dimorphism.
We also investigated the influence of this codon in the s.c. route of infection. The range of incubation periods for all 34 SSBP/1-affected animals was 479 days, (a --95 days) (Fig. 1) , whereas the range within genotype subgroups I, II and III (Fig. 1 ) was considerably smaller: 176, 179 and 254 days, and a of 47, 48 and 64 days, respectively. The shortest incubation periods (mean = 170 days, n = 9) were associated with the (Val/Val)13 n genotype, which in our Cheviots is linked to (Gin/Gin) in codon 171 (Table 3b and Fig. 1 ). The longer incubation periods are associated with sheep of heterozygous (Val/Ala)~3 n genotype, modulated by the genotype in codon 171: the mean incubation peirod of 15 heterozygous (Gln/Arg)m sheep was 100 days (38%) longer than the mean for 10 homozygous (Gin/Gin) m animals ( Table 3b ). The difference of the mean incubation periods between sheep homozygous in these two codons and those sheep heterozygous in both codons is even longer at 190 days. This segregation of affected sheep into three subgroups based on the association of incubation periods with genotypes is significant (P < 0.001). In contrast, survival of s.c. SSBP/1 injection is not correlated with only one genotype in codon 171 (Table 3b) , as was also implied by the data on the i.e. route of infection (Table 3 a).
Discussion
Our previous studies of SSBP/1 scrapie and PrP genotypes in Cheviot sheep resulted in an apparently simple association between one particular polymorphic form of the PrP gene, e.g. the Va1136 allele, and increased susceptibility to disease (Goldmann et al., 1991a) . However, SSBP/1-susceptible sheep have a much lower disease incidence following injection with either BSE or the scrapie isolate CH1641, demonstrating a more complex host genetic control when the agent strain is changed Foster & Dickinson, 1988) .
The data presented here suggest that BSE and CH1641 scrapie induce disease predominantly in PrP genotypes that are homozygous for glutamine at codon 171. The low disease incidence following BSE and CH1641 challenge can therefore be ascribed to PrP allele frequencies (Gln m versus Arg m allele). Conversely, the presence of the Arg171 allele seems to prolong the healthy state of challenged animals at least fourfold in the case of BSE and up to sixfold for CH1641, and consequently these sheep reach their normal average life expectancy without developing the disease.
The modulation of incubation period by codon 136 dimorphism appears minor compared with the major effect of codon 171 dimorphism. Modulation can be described as the lengthening of incubation period of BSE-affected sheep associated with the Valla 6 allele in heterozygous genotypes. A similar association is apparent for CH1641-affected Cheviots because positiveline sheep, presumably Valla 6 allele carriers, have a longer incubation period than negative-line sheep (Foster & Dickinson, 1988) . However, our data show that a shortening of incubation period is also possible when the genotype is homozygous Vala36 (Table 2a) . Hence, the BSE cases and positive-line CH1641-affected sheep (Foster & Dickinson, 1988 ; and unpublished observations) might indicate that variation of incubation period is associated with homozygosity or hetrozygosity at codon 136. A similar association has been discussed for codon 129 of the human PrP gene with SE in man (see below). The extent of the modulation and the full correlation with all three susceptible genotypes remains therefore an interesting question to be addressed in future experiments.
The Arg m allele is dominant in disease prevention after BSE or CH1641 challenge. Does this allele exert a similar influence upon other sources of agents, such as SSBP/1 ? This study has shown that Arg, delays the onset of SSBP/1-induced scrapie by a significant margin, but does not altogether prevent disease. We have confirmed for i.c. SSBP/1 scrapie challenge as for the s.c. infection that the major effect on disease susceptiblity is conferred by codon 136 dimorphism and that the 171 codon modulates the incubation period. Control of incubation period in sheep therefore resembles the tight control seen in rodent SE models much more than is commonly assumed. Nevertheless the relative dominance of Valla 6 over Arg m or vice versa, in disease incidence, provides a useful method to distinguish between SSBP/llike (A-group) and CH1641-1ike (C-group) agents that are present in a flock. The importance of this distinction extends beyond our understanding of the PrP gene-agent interaction to the selection of sheep in an attempt to eliminate scrapie, i.e. selection of sheep for low susceptibility to A-group agents (PrP Alala 6 allele) would inadvertently enrich the genotypes conferring high susceptibility to C-group agents.
We have not observed an association of codon 154 dimorphism with disease, but further experiments are needed to confirm that this dimorphism is silent with respect to disease phenotypes. Our experimental challenges have so far revealed that four out of six PrP genotypes (based on codons 136 and "71) associate with disease susceptibility, which leaves the question of whether there are sources of agent which can affect sheep of genotypes (Ala/Ala)la6 combined with (Gln/Arg)m or (Arg/Arg)lTt. We are currently investigating this issue.
Primary transmission of BSE from cattle to sheep operates in a similar way as sheep-to-sheep transmission of CH 1641 scrapie. There are several sequence differences between ovine and bovine PrP (Goldmann et al., 1991 b) , but the implication of our results is that a single amino acid position can influence the ability of a particular strain of agent to initiate and complete an infection in a new host. Additionally, incubation periods can depend on other single amino acids, i.e. codon 136 in ovine PrP or codons 108 and 189 in murine PrP (Westaway et al., 1987) for BSE transmissions (Fraser et al., 1992) . The species barrier effect (the efficiency of transmission between species) might therefore be described more accurately (at least in this situation) in terms of compatibility between agent strain and PrP genotype. This view is supported by two recent studies with mice carrying chimeric PrP genes (Scott et al., 1993) and with mice expressing only hamster PrP (Bfieler et al., 1993) . The latter implies that successful transmission is dependent on the PrP gene expressed, whereas the former suggests that differences within regions rather than the entire PrP protein influence the extent of a transmission barrier. In conclusion, models using PrP transgenes to overcome these 'barrier effects' may depend for their success on using the correct combination of agent strains and PrP alleles.
Recent analysis of the human PrP gene in cases of sporadic and familial Creutzfeldt-Jakob disease (CJD) and Gerstmann-Str/iussler syndrome have revealed a number of mutant alleles of this gene which appear to influence the likelihood of an individual contracting an SE (for review see Brown, 1992) . In particular, based on distribution studies of variant forms of the PrP gene in samples of patients with CJD it has been proposed that mutations in one PrP protein region appear to control the incidence of disease whereas polymorphisms in other protein regions modify the disease phenotype (Goldfarb et al., 1992a) , with the age of disease onset also dependent on homozygosity of the modifying polymorphism (Baker et al., 1991 ; Palmer et al., 1991) . Closer to the experimental challenge of sheep are iatrogenic CJD cases, caused through growth hormone treatment and tissue transplantation . These CJD patients show a significantly different PrP genotype distribution of a common dimorphism in codon 129 compared to the healthy population Goldfarb et al., 1992b; Labauge et al., 1993) . Therefore, genetic susceptibility (predisposition) similar to sheep scrapie does control some CJD cases. A similar association of a normal allele with disease onset has recently been proposed for Huntington disease (Farrer et al., 1993) .
Our sheep experimental data support the idea of different 'domains' in PrP, which control disease incidence and modulate incubation time, but indicate that the functional effects of these 'domains' can alternate depending on the isolate of agent strain. Whether this dependence exists in CJD remains to be established. Our results confirm that PrP genotypes that are homozygous in the 'modifying' domain have shorter incubation periods than their heterozygous counterparts and emphasize the importance of the strain characteristics in interpreting how a particular PrP genotype will respond to infection. Hence, this basic tenet of the genetics of infectious disease, that phenotype depends on host genotype and strain of pathogen, also applies to SE in a natural host.
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